Tacrolimus or infliximab for severe ulcerative colitis: short-term and long-term data from a retrospective observational study

scientific article

Tacrolimus or infliximab for severe ulcerative colitis: short-term and long-term data from a retrospective observational study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1136/BMJGAST-2014-000021
P932PMC publication ID4599165
P698PubMed publication ID26462273
P5875ResearchGate publication ID273507867

P50authorAli MadianQ86477587
P2093author name stringSatoshi Yamada
Hiroshi Nakase
Minoru Matsuura
Naoki Minami
Takahiko Toyonaga
Takuya Yoshino
Yusuke Honzawa
Yorimitsu Koshikawa
P2860cites workInflammatory bowel disease: clinical aspects and established and evolving therapiesQ21957029
Infliximab for induction and maintenance therapy for ulcerative colitisQ28285876
FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristicsQ28338447
The mechanism of action of cyclosporin A and FK506Q30014847
Cyclosporine in severe ulcerative colitis refractory to steroid therapyQ34060783
Cyclosporine or infliximab as rescue therapy in severe refractory ulcerative colitis: early and long-term data from a retrospective observational studyQ34187731
Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-upQ34506976
Cytomegalovirus colitis complicating inflammatory bowel diseaseQ34572006
A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitisQ35768942
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implicationsQ36477912
Life-event stress induced by the Great East Japan Earthquake was associated with relapse in ulcerative colitis but not Crohn's disease: a retrospective cohort studyQ36649935
Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regressionQ36671830
Thrombosis and inflammatory bowel disease: a call for improved awareness and preventionQ37789688
The pattern and outcome of acute severe colitisQ37814560
Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study.Q37964767
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosisQ38049777
Role in calcineurin inhibitors for inflammatory bowel disease in the biologics era: when and how to use.Q38230163
Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitisQ40323292
Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitisQ41128447
Effects of antiviral therapy for patients with inflammatory bowel disease and a positive intestinal biopsy for cytomegalovirusQ41715872
Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimusQ43024877
Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group.Q43328678
Oral tacrolimus for the treatment of refractory inflammatory bowel disease in the biologic era.Q43497300
Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitisQ43582796
Short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - experience in 130 patientsQ43611596
Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitisQ43798421
Response of refractory colitis to intravenous or oral tacrolimus (FK506).Q44247090
Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitisQ44339242
Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study.Q46531976
Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis.Q46543821
Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs. infliximab.Q50891880
Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial.Q53122367
Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study.Q54007642
Cytomegalovirus infection in patients with ulcerative colitis diagnosed by quantitative real-time PCR analysis.Q54590747
Management of acute severe ulcerative colitisQ57265364
Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitisQ79631486
Management of acute severe colitisQ79922499
Usefulness of quantitative real-time PCR assay for early detection of cytomegalovirus infection in patients with ulcerative colitis refractory to immunosuppressive therapiesQ81167677
Infliximab salvage therapy for patients with ulcerative colitis who failed to respond to tacrolimusQ86122542
P433issue1
P921main subjectcolitisQ2453464
P304page(s)e000021
P577publication date2015-02-20
P1433published inBMJ open gastroenterologyQ27726654
P1476titleTacrolimus or infliximab for severe ulcerative colitis: short-term and long-term data from a retrospective observational study
P478volume2

Reverse relations

cites work (P2860)
Q48853070ATP-binding cassette subfamily B member 1 1236C/T polymorphism significantly affects the therapeutic outcome of tacrolimus in patients with refractory ulcerative colitis.
Q97905242Comparative efficacy of antitumor necrosis factor agents and tacrolimus in naïve steroid-refractory ulcerative colitis patients
Q50097248Comparison of Safety and Efficacy of Tacrolimus versus Infliximab for Active Ulcerative Colitis.
Q26766101Cytomegalovirus and ulcerative colitis: Place of antiviral therapy
Q36317757EFFICACY OF TACROLIMUS FOR INDUCTION OF REMISSION IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Q91729762Effect of Cognitive Behavioral Therapy on Clinical Disease Course in Adolescents and Young Adults With Inflammatory Bowel Disease and Subclinical Anxiety and/or Depression: Results of a Randomized Trial
Q38662186Efficacy and Safety of Tacrolimus Therapy for Active Ulcerative Colitis; A Systematic Review and Meta-analysis.
Q58788974Pooled analysis of the comparative efficacy between tacrolimus and infliximab for ulcerative colitis
Q39041028Short- and Long-Term Outcomes of Infliximab Treatment for Steroid-Refractory Ulcerative Colitis and Related Prognostic Factors: A Single-Center Retrospective Study
Q37338586Sleep disturbances in Japanese patients with inflammatory bowel disease and their impact on disease flare
Q26997361Tacrolimus for the Treatment of Ulcerative Colitis
Q91645954The efficacy of maintenance therapy after remission induction with tacrolimus in ulcerative colitis with and without previous tumor necrosis factor-α inhibitor
Q39586257Treatment of inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2(nd) Asian Organization of Crohn's and Colitis (AOCC) meeting in Seoul

Search more.